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Neutrophil (polymorphonuclear  leukocyte [PMN]) sequestration is one of the histologic hallmarks 
of an acute inflammatory response. During the natural evolution of an inflammatory response, 
PMNs are often replaced by mononuclear cells. This shift in the elicitation of specific leukocyte 
populations usually occurs as the inflammatory lesion enters either the repair/resolution stage 
or progresses  to a chronic inflammation. To elucidate a potential mechanism for the temporal 
change from predominantly PMN recruitment to the presence of monocytes, we postulated that 
PMNs could be a rich source of monocyte chemotactic factors. In our studies, we have identified 
a dose-dependent induction of monocyte chemotactic activity by PMNs treated with lipopoly- 
saccharide (LPS; 1-100 ng/ml). Interestingly, this monocyte chemotactic activity was significantly 
attenuated in the presence  of neutralizing anti-human macrophage inflammatory protein lc~ 
(MIP-I~x) antibodies. Moreover, immunolocalization studies demonstrated the expression of MIP-lot 
by stimulated PMNs. These findings showed that a significant amount of PMN-derived monocyte 
chemotactic activity was attributable to MIP-loe. Subsequent characterization of MIP-lo~ steady- 
state mRNA and antigen expression demonstrated both a dose- and time-dependent production 
by LPS-treated PMNs. Granulocyte/macrophage colony-stimulating factor (GM-CSF), a potent 
PMN activator, failed to induce the expression of MIP-lc~ over a wide range of concentrations. 
However, PMNs stimulated in the presence of both LPS and GM-CSF resulted in a synergistic 
expression pattern for MIP-lc~.  PMNs stimulated in the presence of both GM-CSF and LPS 
demonstrated an enhanced and prolonged expression for both MIP-loe mRNA and antigen, as 
compared with LPS alone. Messenger RNA stabilization analyses demonstrated that MIP-lc~ 
mRNA isolated from PMNs stimulated in the presence of GM-CSF and LPS had a prolonged 
mRNA tl/2,  as compared with LPS alone. These findings support the notion that PMNs are 
capable of producing MIP-lol in the presence of LPS, and that GM-CSF can influence this production 
through prolongation of MIP-lc~  mRNA tl/2.  The production of PMN-derived MIP-lcx, in 
association with the expression of appropriate adhesion molecules at a site of inflammation, may 
be one of the central events that contributes to the temporal shift from predominantly PMNs 
to monocytes during the evolution of inflammation. 
H 
uman peripheral PMNs are the predominant leukocyte 
population at sites of acute inflammatory reactions (1). 
These leukocytes produce a number of inflammatory medi- 
ators,  including reactive oxygen intermediates, arachidonic 
acid derivatives, and enzymes. Recently, a number of investi- 
gators have reported that PMNs can produce several poly- 
peptide mediators of inflammation. Activated PMNs have been 
shown to produce specific cytokines, such as IL-1 (2-5), IL-6 
(6), IL-8 (7-10),  and TNF (11, 12). Since PMNs may com- 
prise up to 80% of the circulating leukocyte pool in humans, 
this biosynthetically active leukocyte population must be con- 
sidered  an important source of cytokines during the early 
phases of inflammation. Previous reports have identified PMNs 
as a source of IL-8, a chemotactic cytokine for neutrophils 
and lymphocytes, at nanomolar and picomolar concentrations, 
respectively. Thus, PMN-derived cytokines may play an im- 
portant role in the early initiation phase of an inflammatory 
response by the induction of the early response cytokines, 
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IL-8.  Whereas this latter cytokine will likely promote the 
continued  recruitment  of neutrophils  to the inflammatory 
lesion, other recruitment factors must be expressed in order 
for the responses to progress to one characterized by the ac- 
cumulation  of monocytes/macrophages. 
Recent investigations  have demonstrated that the chemotac- 
tic cytokine, macrophage inflammatory protein 1 (MIP-1) 1, 
possesses biological activity for activating both neutrophils 
and monocytes/macrophages. Native MIP-1 is comprised of 
two 8-kD polypeptides termed MIP-lo~ and MIP-I~.  This 
chemotactic cytokine is a member of the C-C chemokine su- 
pergene family and is an LPS-inducible, heparin-binding poly- 
peptide first isolated from LPS-treated murine RAW 264.7 
cells (13-16). MIP-lot induces neutrophil chemokinesis, and 
activates neutrophils to generate hydrogen peroxide (14). In 
vivo, MIP-lot can induce a pyrogenic response by acting as 
a prostaglandin-independent  endogenous pyrogen (17). Re- 
cently, it has been reported that MIP-lot-treated murine peri- 
toneal exudate macrophages  exhibited enhanced  antibody- 
independent  macrophage cytotoxicity for tumor targets,  in 
addition to stimulating the secretion of TNF, IL-1, and IL-6 
from this macrophage population  (18).  These data indicate 
that MIP-lot may play a crucial role in the biology of inflam- 
mation  and the pathogenesis of inflammatory  diseases. 
In the present studies, we present data demonstrating that 
PMNs may play an important role in altering the composi- 
tion of leukocytes recruited to an area of inflammation  via 
their ability to generate monocyte chemotactic factors.  Fur- 
thermore,  one of the  major  neutrophil-derived  monocyte 
chemotactic factors is MIP-lot. PMNs challenged with LPS 
demonstrated a time- and dose-dependent increase in both 
steady-state MIP-lot  mRNA  expression,  and  antigen  and 
chemotactic activity. The latter activity was suppressed by 
the addition of neutralizing MIP-lot antibody. Furthermore, 
the expression of MIP-lot mRNA by PMNs stimulated with 
LPS was augmented by GM-CSF, which resulted in the prolon- 
gation of the tt/2 for MIP-lcx mRNA.  These investigations 
suggest that PMNs possess multifunctional activities during 
the initiation and maintenance of an inflammatory reaction 
and are an important  source of this monocyte chemotactic 
cytokine. 
Materials  and Methods 
Reagent Preparation.  Human recombinant GM-CSF (sp act, 4 
x  107 U/mg protein);  G-CSF (sp act, 2  x  10  s U/rag protein); 
Ib3 (sp act, 0.1-0.4 ng/ml);  and MIP-lc~ (sp act, EDs0, 25 ng/ml) 
were purchased from R  & D Systems, Inc. (Minneapolis, MN). 
Cycloheximide (CHX) was purchased from Sigma Chemical Co. 
(St. Louis, MO). Stock LPS (Escherichia coli 0111:B4; Sigma Chem- 
ical Co.) and actinomycin D (Ac-D) (Sigma Chemical Co.) were 
prepared at concentrations of 200/~g/ml in complete medium and 
1  Abbreviations used in this paper: Ac-D, actinomycin D; CHX, cyclohexi- 
mide; hpf, high power field; MCP-1, monocyte  chemoattractant protein 
1; MIP-lct, macrophage inflammatory protein lc~. 
5 mg/ml in DMSO (Sigma Chemical Co.), respectively. Complete 
medium consisted of ILPMI 1640 (Gibco Laboratories, Grand Is- 
land, NY) supplemented with 2 mM t-glutamine,  25 mM Hepes, 
100 U/ml penicillin, 100 ng/ml streptomycin (Hazelton Research 
Products, Lenexa, KS) and 5% heat-inactivated FCS (Gibco Labora- 
tories). Antisera to MIP-lc~ were raised in rabbits immunized with 
recombinant human MIP-lcx using procedures established in our 
laboratory. The antisera to human MIP-lc~ did not cross-react with 
other known members of this chemoattractant  cytokine family, 
including RANTES, monocyte chemoattractant  protein 1 (MCP- 
1), or MIP-1B. All reagents, except LPS, were checked for endo- 
toxin contamination using a limulus amebocyte lysate test kit (QCb 
1000; Whittaker Bioproducts, Inc., Walkersville, MD). The con- 
centration of endotoxin was consistently below 0.01 endotoxin units 
(EU)/ml in all reagents. 
Isolation and Culture Conditions of  PMNs and Monocytes.  Human 
peripheral blood PMNs were obtained from heparinized venous 
blood of healthy volunteers by Ficoll-Hypaque (Pharmacia LKB 
Biotechnology Inc., Piscataway, NJ) centrifugation  and sedimen- 
tation in 5% dextran/0.9% saline. PMNs were subsequently sepa- 
rated from erythrocytes by lysis of erythrocytes  in a solution  of 
0.15 M NH4C1, 0.01 M NaHCO3, and 0.01 M tetra EDTA. The 
recovered PMNs were washed three  times and resuspended at a 
density of 5  x  106 cells/ml in complete medium.  The final cell 
preparation contained more than 99% PMN by morphology and 
nonspecific esterase staining, and viability was more than 98% by 
trypan blue dye exclusion. After Ficoll-Hypaque centrifugation, 
monocytes were purified by counterflow centrifugal elutriation from 
PBMC  (19), and  resuspended  in complete  medium  at  104-106 
cells/ml. PMNs and monocytes were incubated with various con- 
centrations of LPS, and/or GM-CSF. After various periods of time, 
cell-free supernatants of PMN cultures and total PMN RNA were 
collected and stored at  -20~  In some experiments, cell lysates 
of PMN were resuspended and stored in the same volume of com- 
plete medium. 
Assay of Monocyte Chemotactic Activity.  Monocyte chemotaxis 
was performed as previously described (20). For monocyte chemo- 
taxis,  either  150  #1  of supernatant  specimen, 10 -s  M  FMLP 
(Sigma Chemical Co.), MIP-lot (1-100 ng/ml), or HBSS (Gibco 
Laboratories) was placed in duplicate bottomed wells of a modified 
Boyden chemotaxis chamber (Neuro Probe Inc., Cabin John, MD). 
A 5-#m pore size polycarbonate filter (polyvinylpyrrolidone-free, 
Nucleopore Corp.,  Pleasanton, CA) was placed in the assembly 
and 250/xl of mononuclear cell suspension (4  x  106/ml in HBSS) 
placed in each of the top wells. Chemotaxis  chamber assemblies 
were incubated at 37~  in humidified 95% air/5%  COz for 75 
min and the filters removed, fixed in absolute methanol, and stained 
with 2% toluidine blue (Sigma Chemical Co.).  Monocytes that 
had migrated  through  to the bottom of the filter were counted 
in 10 high power fields using the following system: a Javelin chro- 
machip camera (Javelin Electronics, Torrance, CA) attached to a 
Olympus BH-2 microscope, which was interfaced to a computer 
(Macintosh*  II; Apple Computer,  Inc., Cupertino,  CA) with a 
frame grabber (Image Capture 1000; Scion Corp., Walkersvilh, MD) 
and Image 1.40 software .(National Institutes of Health [Nil-I] Public 
Software, Bethesda, MD). Chemotactic Bioactivity was represented 
by the count of migrated monocytes per high power field. In neu- 
tralization experiments, sample supematants were preincubated with 
1:1,000 dilution of rabbit preimmune serum or neutralizing rabbit 
anti-human MIP-lc~ antiserum for 30 min at 37~  and then as- 
sayed for monocyte chemotactic bioactivity. 
Antigen-specific ELISA.  PMN-derived antigenic MIP-lcx quan- 
tified using a modification of a double ligand method, as previ- 
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were  coated with  50  /xl/weU of rabbit  anti-MIP-lc~ antibody 
(1/xg/ml in 0.6 mol/liter NaC1, 0.26 tool/liter H3BO4, and 0.08 
N NaOH, pH 9.6) for 16 h at 4~  and then washed with PBS, 
pH 7.5, 0.05% Tween 20 (wash buffer). Nonspecific  binding sites 
on microtiter plates were blocked with 2% BSA in PBS and in- 
cubated for 90 min at 37~  Plates were rinsed four times with 
wash buffer, and diluted neutrophil-derived conditioned media (50 
/~I) were added, followed by incubation for 1 h at 37~  Plates 
were washed four times with wash buffer, then 50/~l/well of bi- 
otinylated rabbit anti-MIP-lot was added and incubated for 30 min 
at 37~  After washing of  plates, chromogen substrate was added. 
The plates were incubated at room temperature to the desired ex- 
tinction,  and the reaction terminated with 50/~l/well of 3 M 
H3SO4 solution, and were read at 490 nm in an ELISA reader. 
This ELISA method consistently had a sensitivity limit of ,,~50 
pg/ml. 
lmmunohistochemistry.  PMNs (5.0  x  106/ml) were incubated 
with LPS (100 ng/ml) and/or GM-CSF (10 U/ml) for 24 h, and 
deposited on a glass slide  by using a Cytospin II (Shandon  Southern 
Instruments, Inc., Sewickley,  PA). After air-drying,  slides  were fixed 
by 4% paraformaldehyde  in PBS for 10 min. Before staining, the 
slides were again fixed for 30 min in ice-cold acetone. Endogenous 
peroxidase activity was quenched by incubating the slides for 30 
min in absolute methanol and 3% hydrogen  peroxide. After rinsing 
in PBS, the slides were blocked with a 1:50 dilution of normal goat 
serum for 30 min at 37~  then treated for 2 h at 37~  with a 
1:800 dilution of rabbit anti-human MIP-lcz serum or the same 
dilution of preimmune rabbit serum. After incubation, prepara- 
tions were rinsed three times with PBS, overlaid  with biotinylated 
goat anti-rabbit IgG (1:200; Vector  Laboratories  Inc., Burlingame, 
CA), incubated 20 min, and rinsed three times with PBS. The slides 
were then treated with streptavidin conjugated to peroxidase for 
15 min at 37~  rinsed three time with PBS, overlaid with 100 
txl of equal vol of 3-amino-9-ethylcarbazole 40 mg/ml in N,N- 
dimethylformamide, (Sigma Chemical Co.), and treated with 3% 
hydrogen peroxide in 0.1 M sodium acetate for 15 min at 37~ 
to allow color development. After rinsing with distilled water, the 
slides were stained with Mayer's hematoxylin. In competitive inhi- 
bition studies, to demonstrate antibody specifidty,  immunostaining 
for human MIP-lce showed 100% inhibition by the addition of 
exogenous recombinant MIP-lcr 
Isolation of Total PMN RNA and Northern Blot Analysis.  Total 
cellular RNA from PMN was isolated as previously  described (8). 
Briefly, guanidine isothiocyanate  solution containing 25 mM Tris, 
pH 8.0, 4.2 M guanidine isothiocyanate,  0.5% Sarkosyl,  and 0.1 M 
2-ME was added to PMN pellets. After homogenization, the above 
suspension was added to a solution containing an equal volume 
of 100 mM Tris, pH 8.0, 10 mM EDTA, and 1.0% SDS. The mix- 
ture was then extracted with chloroform-phenol and chloroform- 
isoamyl alcohol. The RNA was alcohol-precipitated  and the pellet 
dissolved in diethyl pyrocarbonate-treated H20.  Total RNA was 
separated by Northern blot analysis  using formaldehyde,  1% agarose 
gels, transblotted to nitrocellulose, baked, prehybridized, and hy- 
bridized with a 32p-5' end-labeled oligonucleotide probe specific 
for human MIP-lc~ or/~-actin. The 30-mer oligonucleotide probe 
for MIP-lcr was complementary to nucleotides 105-134 (5'-GAG- 
AGC-CAT-GGT-GCA~GAG-GAG-GAC-AGC-AAG-3') (22). The 
42-mer oligonucleotide probe for ~/-actin was complementary to 
nucleotides 432-473 (5'-GGC-TGG-GGT-GTT-GAA-GGT-CTC- 
AAA-CAT-GAT-CTG-GGT-CAT-CTT-3')  (23). Blots were washed 
and exposed to X-ray film. Specific  cytokine mRNA was quantified 
using imaging analysis  with the Image Capture 1000 flame grabber 
and Image 1.40 software. 
StatisticalAnalysis.  Data were analyzed  by Macintosh  |  II com- 
puter using a statistical  software  package (Statview  II; Abacus  Con- 
cepts, Inc., Berkeley,  CA) and expressed as mean _+ SEM. Groups 
of data were evaluated  by analysis  of variance. Data that appeared 
statistically significant were compared by Student's t test for com- 
paring the means of multiple groups, and considered significant 
if p values were <0.05. 
Results 
Activity of  Monocyte Chemotaxis in PMN-conditioned Medium. 
In initial studies, we examined whether LPS-stirnulated PMNs 
were capable of producing chemotactic factors for monocytes. 
Conditioned media from PMNs (PMN-CM) stimulated with 
graded doses of LPS (1-100 ng/ml) for 24 h were shown to 
possess significant monocyte chemotactic activity (Table 1). 
PMN-CM challenged with 10 ng/ml LPS demonstrated a 
significant increase in monocyte chemotactic activity, as com- 
pared with control (CTR)-CM (11.9 vs 5.5 ceUs/high power 
field [hpq, respectively).  PMNs challenged with the max- 
imum concentration of LPS used in this study, 100 ng/ml, 
produced a monocyte chemotactic activity which was ,,050% 
of the FMLP positive control, 14.0 vs 30.5 cells/hpf, respec- 
tivdy. To address  the potential role of residual LPS in the 
PMN supernatant to alter monocyte chemotaxis, we assessed 
the monocyte chemotactic activity of recombinant human 
MIP-lot in the presence and absence of graded doses (1-100 
ng/ml) of LPS.  In these studies LPS, at various doses,  did 
not alter in vitro monocyte chemotaxis to 10 ng/ml of MIP- 
lc~ (data not shown). We examined the specificity of  the mono- 
cyte chemotactic activity produced by the PMNs by adding 
neutralizing antibody directed against MIP-lc~ to the PMN- 
CM before assessing chemotactic activity. The neutralizing 
antibody to MIP-lot reduced the PMN-derived chemotactic 
activity by "~60% (Table 1). hrMIP-lot also had the ability 
to dose dependently induce monocyte chemotaxis, which was 
suppressed  by our antibody to MIP-lc~.  Antibodies from 
preimmune sera had no significant effect on the PMN-derived 
monocyte chemotactic activity. These initial studies demon- 
strated that part of the activity produced by LPS-stimulated 
PMNs was attributable to MIP-lcr 
Production of  Antigenic MIP-lcr  from PMNs.  Based on the 
above findings, we began a series of investigations to assess 
the expression of PMN-derived antigenic MIP-lc~. As shown 
in Fig. 1, PMNs produced MIP-lol over a wide concentration 
range of LPS (0.1-1,000  ng/ml). Significant levels of PMN- 
derived MIP-lot were produced in response to LPS concentra- 
tions in the nanogram per milliliter range. Since GM-CSF 
was previously shown to induce PMN cytokine expression 
(3,  6,  10, 24),  we examined the effect of this polypeptide 
on PMN-derived MIP-lcr  (Fig.  t). In this study, GM-CSF 
was not an effective stimulus for the production of PMN- 
derived MIP-lc~ when assessed over a 5-log concentration 
range of GM-CSF. In addition, both IL-3 and G-CSF were 
also found to be ineffective in inducing MIP-lot expression 
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Cells/hpf 
CTK sera  anti-MIP sera  Percent 
Condition  (1:1,000)  (1:1,000)  suppression 
FMLP (10 -s M)  30.5  _+  2.86*  31,2  _+  2.15  -0.02%~ 
CTR-CM  5.5  -+  1.42  2.4  +  0.82  56.4% 
LPS  (1  ng/ml)  6.6  +  1.14  2.6  _+  0.71  60.6% 
LPS  (10 ng/ml)  11.9  _+  1.54  2.5  +  1.00  79.0% 
LPS  (100 ng/ml)  14.0  _+  1.35  5.6  +_  1.14  60.0% 
hrMIP-lc~ (1  ng/ml)  13.9  _+  2.09  4.9  +  1.58  64.7% 
hrMIP-lo~ (10 ng/ml)  25.7  +_  1.52  8.8  _+  1.14  65.8% 
hrMIP-lc~ (100 ng/ml)  26.6  +  3.34  9.8  +  1.76  63.2% 
* The results represent the mean _  SEM of migrated  monocytes of 10 hpf done in duplicate wells. These values were  subtracted mean values of 
HBSS plus CTR sera (8.7 cells/hpf),  and of HBSS •  anti-MlP sera (7.7 cells/hpf),  respectively. 
t The percent suppression was calculated by subtracting the values of anti-MIP-l~x serum (anti-MIP sera)-treated conditioned media from preimmune 
serum (CTR-sera)-treated  conditioned media,  and dividing by the values of anti-MIP-lcx serum (anti-MIP sera)-treated  conditioned media. 
by PMNs (data not shown). However, GM-CSF was found 
to possess synergistic activity in the presence of LPS. As shown 
in Fig. 2, the addition of 10 U/ml of GM-CSF in the pres- 
ence of graded doses of LPS was sufficient to increase the 
expression of PMN-derived MIP-lo~.  These results demon- 
strated that PMN-derived MIP-la  production was signi- 
ficantly increased in the presence of LPS (100 ng/ml) plus 
10 U/ml GM-CSF (7.75  _+  1.48 ng/ml), as compared with 
100 ng/ml of LPS alone (3.13  +_ 0.92 ng/ml). We next de- 
termined the temporal expression pattern for PMN-derived 
MIP-lol in response to either LPS, GM-CSF, or LPS plus 
GM-CSF (Fig. 3 A). Antigenic MIP-lo~ production by LPS 
(100 ng/ml)-treated PMNs was detected first at 8 h and peaked 
at 36 h after stimulation. A similar kinetic pattern for the 
cT. o.1  ,  lo  1~  ,o.1  1  lo  loo,ooo 
GM-CSF (U/ml)  LPS (ng/ml) 
Figure  1,  The  concentration effect of neutrophil-derived  antigenic 
MIP-la production in response to  a dose-dependent  manner of LPS 
(0.1-1,000 ng/ml) or GM-CSF (0.1-100 U/ml). Supernatants were har- 
vested 24 h after stimulation and assessed for antigenic MIP-I~ by ELISA. 
Neutrophil-derived  antigenic MIP-la is expressed as the mean (ng/ml) 
_+  SEM of supernatant.  (*) p values <  0.05,  as compared with CTR. 
(.  =  6). 
expression of antigenic MIP-let was observed when PMNs 
were treated with LPS plus GM-CSF (10 U/ml). However, 
GM-CSF alone was not shown to induce MIP-lc~ expression 
over the 48-h time period. Since certain cytokines have been 
reported to remain ceU-associated after stimulation, we de- 
termined the kinetics of MIP-lot levels in PMN cell lysates 
(Fig. 3 B). Whereas the kinetic pattern for the production 
of MIP-lot was similar between the supernatant and cell ly- 
sates, the latter had approximately threefold higher levels of 
MIP-loe. Interestingly, lysates of freshly isolated,  and non- 
stimulated PMN contained detectable levels of antigenic MIP- 
lo~. The constitutive expression  of cell-associated MIP-lc~ 
may play an important role in the initiation and maintenance 
of inflammation by locally releasing a cytokine important to 
a 
CTR  0.1  1  10  100  1000 
GM-CSF  I  I 
(lOU/ml)  LPS (ng/ml) 
+ 
GM-CSF 
Figure 2.  The concentration effect of neutrophil-derived  antigenic 
MIP-lo~ production in response  to  a dose-dependent  manner of LPS 
(0.1-1,000 ng/ml) plus 10 U/ml GM-CSF. The superuatants were har- 
vested 24 h after stimulation. Neutrophil-derived antigenic MIP-lo~  is ex- 
pressed as the mean (ng/ml) _+ SEM of supernatant. (*)p values < 0.05, 
as compared with similar LPS concentration in Fig.  1.  (n  =  6). 
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Figure 3.  The time course for the production of PMN-derived MIP-I(x 
production in response to either  LPS, GM-CSF, or LPS plus GM-CSF. 
PMNs were stimulated at time 0 with either  LPS (100 ng/ml) (--4~), 
GM-CSF (10 U/ml) (~),  LPS plus GM-CSF (-l-), or CTR (-O-). 
(.4) Supernatants or (B) lysates were collected at 1, 2, 4, 8, 24, 36, and 
48 h after stimulation. Neutrophil-derived antigenic MIP-lc~ is expressed 
as the mean (ng/ml) -+ SEM of supernatant. (*)p values < 0.05, as com- 
pared with LPS alone and CTR. (n  =  5). 
cell elicitation upon PMN lysis in vivo. Thus, MIP-la may 
provide a crucial mechanism for the local accumulation of 
MIP-loc and aid in further leukocyte recruitment. The via- 
bility of PMNs treated with either GM-CSF, LPS, or LPS 
plus GM-CSF was not found to be significantly altered during 
the study period as determined by trypan blue dye exclusion 
(data  not shown). 
Since the monocyte has been previously identified as a rich 
source of MIP-la, it was important to rule out this cell as 
a major source of MIP-lo~ in these PMN studies. Although 
the PMN preparations were usually >99% PMNs, as assessed 
by morphology and nonspecific esterase staining, we further 
examined the potential contribution of monocyte-derived 
MIP-lc~ produced by different concentrations of monocytes. 
As shown in Table 2, LPS stimulated monocytes at 1-5  x 
104 cells/ml (equivalent to  0.2-1%  of PMN  suspension) 
were able to produce only 0.26  _+ 0.04 ng/ml of MIP-lol, 
whereas MIP-lo~ production from 5  x  10  s cells/ml (equiva- 
lent to 10% of PMN) produced 4.20  +_ 0.35 ng/ml. These 
data indicated that the levels of MIP-lc~ production in our 
PMN preparations were not based solely on monocyte con- 
tamination. 
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Imraunocytocheraical Demonstration of PMN-derived MIP- 
1or.  To localize antigenic MIP-lol to stimulated PMNs, cell 
preparations were challenged with LPS (100 ng/rrd) plus GM- 
CSF (10 U/m1) for 24 h and assessed by immunohistochem- 
istry. As shown in Fig. 4, PMNs treated with LPS plus GM- 
CSF demonstrated a significant staining pattern for MIP-lol 
antigen (Fig. 4, B and/9). However, PMNs treated in a similar 
fashion, but stained using preimmune serum (Fig. 4, A and 
C) demonstrated little nonspecific staining for MIP-lo~. These 
studies demonstrate that MIP-loL is produced by stimulated 
PMNs and corroborate the above findings that MIP-lo~ is 
cell associated. 
Kinetics of  MIP-Icr mRNA Expression in PMN.  To deter- 
mine whether increases in MIP-lcx antigen are accompanied 
by similar increases in MIP-lot mRNA levels, we examined 
the expression of steady-state  levels of PMN-derived MIP- 
lo~ mRNA.  PMNs were incubated with either LPS (100 
ng/ml), GM-CSF (10 U/m1), or LPS plus GM-CSF and total 
RNA isolated from cells at 1, 4,  8,  24, 36, and 48 h. As 
shown in Fig.  5,  the expression  of MIP-la mRNA from 
PMNs stimulated with GM-CSF alone was essentially  undetec- 
table throughout the study period, whereas LPS was able 
to induce significant levels of steady-state MIP-lol mRNA. 
The maximum expression for MIP-lc~ occurred 24 h after 
LPS stimulation. Interestingly,  the addition of GM-CSF plus 
LPS significantly augmented the steady-state levels of MIP-lc~ 
mRNA, as compared with LPS. Steady-state levels of MIP-lc~ 
mRNA were undetectable in unstimulated, freshly isolated 
PMNs or in PMNs incubated with medium alone (data not 
shown). To determine whether the expression of MIP-lc~ was 
dose dependent, concentration effect studies were conducted 
in the presence of graded doses of GM-CSF in the presence 
or absence of 10 ng/ml of LPS (Fig. 6). Steady-state levels 
of MIP-loe mtLNA were not expressed over a wide concen- 
tration range of GM-CSF. However, the addition of 10 ng/ml 
of LPS plus graded doses of GM-CSF resulted in an increase 
in the expression of steady-state levels of MIP-lc~ mRNA. 
We next examined the effect of CHX and Ac-D on PMN- 
derived MIP-lot mRNA expression.  As seen in Fig.  7, the 
addition of CHX augmented MIP-lo~ mRNA expression in 
PMNs stimulated with LPS and/or GM-CSF.  Furthermore 
Ac-D completely inhibited MIP-lo~ expression by LPS and/or 
GM-CSF-stimulated PMNs. These studies suggest that MIP- 
lot expression by PMNs is expressed de novo after stimula- 
tion and that the PMN is susceptible to superinduction by 
CHX. Thus, the production of MIP-lcr by PMNs is likely 
controlled by intracellular regulatory proteins, a phenomenon 
associated with the regulation of a variety of other cytokines. 
Effect of  GM-CSF on MIP-Icr mRNA Stability.  The above 
data suggested that GM-CSF could induce a synergistic effect 
on the expression of PMN-derived MIP-lo~ mtLNA. To fur- 
ther investigate a possible mechanism for the effect of GM- 
CSF in this system, we performed the following MIP-lo~ 
mRNA stability experiments to assess the half-life of this 
PMN-derived cytokine. After 24-h incubation with LPS (100 
ng/ml) and/or GM-CSF (10 U/ml), Ac-D (5/zg/ml) was 
added to PMN culture and total RNA isolated  at specific 
time points. As shown in Fig. 8, MIP-lc~ mRNA from PMNs Figure 4.  Low (x 200)- and high 
(x 400)-power photomicrographs  of 
immunohistochemical localization 
of PMN-derived MIP-lo~.  PMNs 
stimulated with LPS plus GM-CSF 
for 24 h were deposited on a glass 
slide, and stained with either anti- 
MIP-lc~  antibody  or  preimmune 
sera. (A and C) Control staining by 
preimmune sera. (B and D) Positive 
staining by anti-MIP-l~ sera. 
Figure  5.  The  time  course  of 
neutmphil-derived steady-state levels 
of MIP-lol mRNA in response to 
LPS, GM-CSF, and LPS plus GM- 
CSF. Neutrophils were stimulated 
at  time  0  with  either  LPS  (100 
ng/ml), and/or GM-CSF (10 U/ml) 
and total RNA was isolated at 1, 
4, 8, 24, 36, and 48 h after stimula- 
tion. (A) Representative  Northern 
b~ots of neutrophil-derived steady- 
state MIP-1oe mRNA.  (B) Corre- 
sponding density of the Northern 
blots in A. (C) Equivalent  loading 
of total RNA was determined by 
equal levels of steady-state/~-actin 
mRNA level per lane. 
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MIP-loe 
1  x  104*  5  x  104  1  x  105  5  x  105  1  x  106 
Condition  (0.2%o)*  (1~  (2%0)  (10%)  (20%) 
CTR  NDS  0.07  _+  0.02  0.16  _+  0.03  0.36  _+  0.06  3.32  _+  0.56 
GM-CSF  (10  U/ml)  ND  0.05  +  0.02  0.19  _+  0.04  0.51  +  0.08  3.19  _+  0.37 
LPS  (100  ng/ml)  ND  0.26  _+  0.04  0.97  _+  0.13  4.20  _+  0.35  10.24  _+  1.20 
LPS  +  GM-CSF  ND  0.26  -+  0.02  0.76  _+  0.07  3.92  _+  0.42  12.50  _+  1.73 
* Monocytes (cells/m1) were resuspended  in complete media  at  various  concentrations,  and  incubated  for 24 h. 
* Percentage  would he equivalent  to that  of monocytes  potentially contaminating  the PMN cultures. 
S ND,  Not  detected. 
treated with GM-CSF plus LPS possessed a markedly pro- 
longed  tl/2,  as compared with LPS alone (LPS,  2 h  vs LPS 
plus GM-CSF, 5 h) (Fig.  8 B). In these studies, the stability 
of B-actin mRNA isolated from PMNs treated with LPS or 
LPS plus GM-CSF did not appear to be altered. In total, the 
above studies demonstrate that  GM-CSF may be an impor- 
tant polypeptide mediator for the continued maintenance of 
an inflammatory response via its ability to augment  the ex- 
pression  of PMN-derived chemotactic  cytokines. 
Discussion 
PMNs are usually recognized as an important  leukocyte 
population involved in acute inflammatory responses.  Histor- 
ically,  this cell population was not considered an important 
source of de novo polypeptide mediators, and its role in host 
defense was felt to occur only via its phagocytic activity and 
Figure  6.  The concentration effect of neutrophil-derived  steady-state 
levels of MIP-lo~ mRNA in response to a dose-dependent  manner of GM- 
CSF in the absence or presence of 10 ng/ml of LPS. Neutrophils were 
stimulated  with graded concentrations  of GM-CSF (0.1-100 U/ml) with 
or without LPS (10 ng/ml), and total RNA was isolated at 8 h after stim- 
ulation. (A) Representative  Northern blots of neutrophil-derived  steady- 
state MIP-lol mRNA. (B) Corresponding density  of the Northern blots 
as assessed by image analysis. (C) Equivalent loading of total RNA as de- 
termined by equal levels of steady-state 3-actin mRNA level per lane. 
Figure  7.  The effect of CHX, or Ac-D on neutrophil-derived  steady- 
state levels of MIP-lce mRNA in response to LPS, GM-CSF, or LPS plus 
GM-CSF. Neutrophils were preincubated with CHX (5/~g/ml), or Ac-D 
(5/ig/ml) for 1 h  and  stimulated  with LPS (100 ng/ml), GM-CSF (10 
U/ml), or LPS plus GM-CSF. Total RNA was isolated at 4 h after stimu- 
lation. (A) Representative  Northern blots of neutrophil-derived  steady- 
state MIP-lc~ mRNA. (B) Corresponding  density of imaging analysis. (C) 
Equivalent loading of total RNA was determined by equal levels of steady- 
state 13-actin mRNA level per lane. 
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Figure  8.  The half-life of neutrophil-defived  steady- 
state levels of MIP-la mRNA in response to LPS, or LPS 
plus GM-CSF. Neutrophils were stimulated with LPS (100 
ng/ml) or LPS plus GM-CSF (10 U/ml). After 24-h incu- 
bation,  Ac-D (5 #g/ml) was added and total RNA was 
isolated at various time points. (A) (I and I/) Representa- 
tive  Northern  blots  of nentrophil-derived  steady-state 
MIP-lot mRNA. (III and IV) Equivalent loading of total 
RNA  was  determined  by equal  levels of steady-state 
/3-actin mRNA level per lane. (B) Corresponding  density 
of the image  analysis. 
the production and release of enzymes and reactive oxygen 
species. However, recent data have demonstrated that PMNs 
are  biosynthetically active  and  can  produce  a  variety  of 
cytokines known to play an important role in inflammation. 
These cytokines include: IL-1 c~ and 3  (2-5), IL-6 (6), IL-8 
(7-10), TNF-ot (11, 12), and IL-1 receptor antagonist (24). 
Since PMNs are one of the first cells to arrive  at a site of 
inflammation, the cytokine secreting activity of these cells 
may indicate a role for PMNs during the maintenance of an 
inflammatory site. 
The progression and maintenance of many inflammatory 
responses are often histologically defined by a significant PMN 
recruitment phase followed  by the elicitation of mononuclear 
cells. This temporal appearance of specific leukocytes would 
suggest that the PMN may play a role in mononuclear cell 
recruitment. However, few studies have actually demonstrated 
that PMNs can generate a chemotactic factor(s) for mono- 
cytes. In the present study, we demonstrated that peripheral 
blood PMNs were a significant  source of MIP-lot, which 
is a potent chemoattractant for monocyte. MIP-lc~ belongs 
to a supergene family of chemotactic cytokines which are 
identified by the location of four cysteine amino acids; two 
of the cysteines are found in juxtaposition to each other. This 
family contains other chernotactic cytokines, including MCP-1, 
R.ANTES, and MIP-I~. In addition, this group of  chemotactic 
cytokines is distantly related to another supergene family of 
neutrophil chemotactic factors, which includes IL-8. These 
cytokines appear to play a key role in inflammation and im- 
mune responses by their chemotactic activities and their ability 
to activate PMNs, monocytes, T ceils, eosinophils, and baso- 
phils (16, 25-27). MIP-lot has been shown to possess a va- 
riety of biological activities, including the induction of neu- 
trophil chemokinesis and activation of neutrophils to generate 
hy&ogen peroxide (14), serving as a prostaglandin-independent 
endogenous pyrogen (17), stimulating the secretion of TNF, 
IL-lot, and IL-6 from murine peritoneal macrophages (18), 
and inducing the chemotaxis of basophils and histamine re- 
lease from mast cells (28). 
In this study, LPS challenge (8-36 h) was identified as an 
important stimulus for the expression of PMN-derived MIP- 
lot. Interestingly, GM-CSF, an inflammatory mediator pre- 
viously identified as a stimulus for PMN-derived cytokines, 
did not induce the expression of PMN-derived MIP-lc~ alone, 
but did cause a significant  synergistic rise in the production 
of PMN-derived MIP-lol. The mechanism for the increase 
in MIP-lot production by GM-CSF plus LPS appeared to be 
due to the stabilization  of MIP-lc~ mRNA, resulting in a 
prolonged mRNA tv2. Whereas mRNAs which code for 
various structural proteins are quite stable, recent studies have 
identified mRNAs that code certain inducible proteins, in- 
cluding cytokines, oncogenes, and some enzymes, are rela- 
tively unstable and possess half-lives on the order of 10-60 
rain (29). Furthermore, the "AUUUA" nucleotide motif in 
the 3' untranslated region has been identified as playing an 
important role in regulating the longevity of many cytokine 
mRNA species. This motif appears to have relevance for the 
rapid decay of specific cytokine mRNA (29,  30).  Interest- 
ingly, MIP-lcr does possess this motif in the 3' untranslated 
region of its mRNA (14, 15, 23, 31). 
GM-CSF is likely to play an important role during the 
maintenance of an inflammatory  lesion not only by increasing 
the production of a PMN-derived monocyte chemotactic 
cytokine, but also by increasing the longevity of PMNs them- 
selves. Recent studies have demonstrated that GM-CSF can 
increase the survival of PMNs as they participate in inflam- 
mation and prolong the circulating halfqife of PMNs in vivo 
70  Macrophage  Inflammatory Protein  lcx Expression in Neutrophils (32, 33). PMNs appear to be susceptible to GM-CSF stimu- 
lation as a number of cytokines, including IL-1, IL-1 receptor 
antagonist, IL-6, G-CSF, and M-CSF are produced by PMNs 
challenged  with GM-CSF (3,  6,  10,  24).  However, in the 
above studies we could not detect the expression of MIP-lol 
by PMNs stimulated with GM-CSF alone. The above findings 
demonstrate that PMNs are an important source of the mono- 
cyte chemotactic protein MIP-lc~ and the expression of this 
chemotactic cytokine is regulated by both exogenous and en- 
dogenous factors. The production of MIP-lol by stimulated 
PMNs could conceivably place this cell in a key position to 
orchestrate the switch in leukocyte infiltration from the acute 
PMN response to more chronic mononuclear cell recruitment. 
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